Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2183440-56-2 | Sulfo-Cy7 alkyne | AA019EG6 | MFCD31580104
20491-91-2 | 2,4,5-Trimethoxyphenol | AA019EJQ | MFCD17015434
41589-41-7 | diethyl 2-cyclobutylidenemalonate | AA019EMN | MFCD22575251
1250998-75-4 | tert-Butyl 1-(trifluoromethyl)-2,8-diazaspiro[4.5]decane-8-carboxylate | AA019EQ8 | MFCD14581162
1326242-72-1 | Di-tert-butyl 1-(bicyclo[1.1.1]pentan-1-yl)hydrazine-1,2-dicarboxylate | AA019ETA | MFCD29917057
927438-48-0 | 3-(2-chloro-4-hydroxy-phenyl)-acrylic acid | AA019EWG | MFCD02669929
1824592-95-1 | thieno[3,4-c]pyridine-1,3-diamine | AA019EZF | MFCD22422803
82451-48-7 | N1,N6-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine compound with 4-(4,6-dichloro-1,3,5-triazin-2-yl)morpholine(Poly) | AA019FTV | MFCD00197892
1396999-93-1 | 2-[(2-fluorophenyl)formamido]-3-methylbutanoic acid | AA019GEW | MFCD03951018
872107-72-7 | 3-[(3,5-dimethylpiperidin-1-yl)sulfonyl]-4-methoxybenzoic acid | AA019GLK | MFCD06660481
